Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -12.67%441.49K | -33.55%449.17K | -21.98%517.04K | 4.40%3.18M | -14.29%1.33M | -41.14%505.57K | 71.43%675.92K | 149.39%662.69K | 3.04M | 1.55M |
| Selling and administrative expenses | -20.81%310.34K | -40.98%320.97K | -27.82%367.96K | -10.95%2.36M | -29.13%907.96K | -52.27%391.87K | 59.16%543.87K | 150.99%509.8K | --2.65M | --1.28M |
| -Selling and marketing expense | --150K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -General and administrative expense | -59.08%160.34K | -40.98%320.97K | -27.82%367.96K | -10.95%2.36M | -29.13%907.96K | -52.27%391.87K | 59.16%543.87K | 150.99%509.8K | --2.65M | --1.28M |
| Research and development costs | 58.41%40.13K | -5.21%36.76K | -23.68%29.49K | -20.01%128.77K | -79.36%26.01K | 408.16%25.33K | 29.29%38.79K | 28.80%38.64K | --160.98K | --125.99K |
| Depreciation amortization depletion | 0.25%81.4K | 0.25%81.4K | 0.25%81.4K | 345.59%325.28K | 11.90%81.68K | --81.2K | --81.2K | --81.2K | --73K | --73K |
| -Depreciation and amortization | 0.25%81.4K | 0.25%81.4K | 0.25%81.4K | 345.59%325.28K | 11.90%81.68K | --81.2K | --81.2K | --81.2K | --73K | --73K |
| Other operating expenses | 34.46%9.63K | -16.87%10.03K | 15.55%38.19K | 126.80%364.33K | 334.28%315.12K | -78.23%7.16K | -46.54%12.07K | 1.32%33.05K | --160.64K | --72.56K |
| Operating profit | 12.67%-441.49K | 33.55%-449.17K | 21.98%-517.04K | -4.40%-3.18M | 14.29%-1.33M | 41.14%-505.57K | -71.43%-675.92K | -149.39%-662.69K | -3.04M | -1.55M |
| Net non-operating interest income (expenses) | 0 | -5.55K | 113.78%7.04K | 7.04K | 0 | 0 | 0 | -51.1K | 0 | |
| Non-operating interest income | ---- | ---- | ---- | --7.04K | --2.79K | --4.25K | ---- | ---- | --0 | --0 |
| Non-operating interest expense | --0 | --5.55K | ---- | --0 | --0 | --0 | --0 | --0 | --51.1K | --0 |
| Other net income (expenses) | 101.46%102.8K | -838 | -1.04K | -7.04M | -2.59M | |||||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---838 | ---1.04K | ---1.04K | ---- |
| Special income (charges) | ---- | ---- | ---- | 101.46%102.8K | 103.97%102.8K | ---- | ---- | ---- | ---7.04M | ---2.59M |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --7.04M | --2.59M |
| -Less:Other special charges | ---- | ---- | ---- | -101.46%-102.8K | ---- | ---- | ---- | ---- | --7.04M | --2.59M |
| Income before tax | 12.67%-441.49K | 32.73%-454.72K | 21.98%-517.04K | 69.75%-3.07M | 70.54%-1.22M | 90.51%-505.57K | -63.55%-675.92K | -134.03%-662.69K | -10.14M | -4.14M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 12.67%-441.49K | 32.73%-454.72K | 21.98%-517.04K | 69.75%-3.07M | 70.54%-1.22M | 90.51%-505.57K | -63.55%-675.92K | -134.03%-662.69K | -10.14M | -4.14M |
| Net income continuous operations | 12.67%-441.49K | 32.73%-454.72K | 21.98%-517.04K | 69.75%-3.07M | 70.54%-1.22M | 90.51%-505.57K | -63.55%-675.92K | -134.03%-662.69K | ---10.14M | ---4.14M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 12.67%-441.49K | 32.81%-454.73K | 21.98%-517.04K | 69.75%-3.07M | 70.32%-1.22M | 90.51%-505.57K | -63.76%-676.76K | -134.03%-662.69K | -10.14M | -4.11M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 12.67%-441.49K | 32.81%-454.73K | 21.98%-517.04K | 69.75%-3.07M | 70.32%-1.22M | 90.51%-505.57K | -63.76%-676.76K | -134.03%-662.69K | -10.14M | -4.11M |
| Diluted earnings per share | 0.00%-0.01 | 0.00%-0.01 | 66.67%-0.01 | 77.27%-0.05 | 69.66%-0.02 | 83.33%-0.01 | -50.02%-0.01 | -556.89%-0.03 | -0.22 | -0.0659 |
| Basic earnings per share | 0.00%-0.01 | 0.00%-0.01 | 66.67%-0.01 | 77.27%-0.05 | 69.66%-0.02 | 83.33%-0.01 | -50.02%-0.01 | -556.89%-0.03 | -0.22 | -0.0659 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.